{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=AlloVir", "query": { "sponsor": "AlloVir" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=AlloVir&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-25T16:21:10.304Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04933968", "title": "Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Respiratory Tract Viral Infections", "Human Metapneumovirus (hMPV) Infection", "Parainfluenza (PIV) Infection", "Respiratory Syncytial Viral (RSV) Infection", "Influenza Infection" ], "interventions": [ { "name": "ALVR106", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "17 Years to 75 Years" }, "enrollment_count": 17, "start_date": "2022-03-21", "completion_date": "2024-01-31", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 21, "location_summary": "Scottsdale, Arizona • Duarte, California • Gainesville, Florida + 16 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04933968" }, { "nct_id": "NCT04693637", "title": "Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Adenovirus Infection", "BK Virus Infection", "Cytomegalovirus Infections", "Epstein-Barr Virus Infections", "Human Herpes Virus-6 Infection", "JC Virus Infection" ], "interventions": [ { "name": "Posoleucel (ALVR105)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 26, "start_date": "2021-01-15", "completion_date": "2023-01-19", "has_results": true, "last_update_posted_date": "2024-05-09", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Duarte, California • San Francisco, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Northwest Rectangle", "state": "District of Columbia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04693637" }, { "nct_id": "NCT05305040", "title": "Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Adenovirus Infection", "BK Virus Infection", "Cytomegalovirus Infections", "Epstein-Barr Virus Infections", "Human Herpes Virus-6 Infection", "JC Virus Infection" ], "interventions": [ { "name": "Posoleucel (ALVR105)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 451, "start_date": "2022-03-24", "completion_date": "2024-01-30", "has_results": true, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Duarte, California + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05305040" }, { "nct_id": "NCT02108522", "title": "Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Infection" ], "interventions": [ { "name": "Multivirus Specific T cells", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 82, "start_date": "2014-06", "completion_date": "2019-12", "has_results": true, "last_update_posted_date": "2021-07-20", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02108522" }, { "nct_id": "NCT04605484", "title": "Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "BK Virus Nephropathy", "BK Virus Infection" ], "interventions": [ { "name": "Posoleucel (formerly known as ALVR105) cells", "type": "BIOLOGICAL" }, { "name": "Placebo (visually identical to Posoleucel)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 61, "start_date": "2021-03-22", "completion_date": "2022-10-20", "has_results": true, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 33, "location_summary": "Los Angeles, California • Palo Alto, California • Sacramento, California + 27 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04605484" }, { "nct_id": "NCT01570283", "title": "ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Viral Infection" ], "interventions": [ { "name": "Multivirus-specific T cells Dose Level 1", "type": "BIOLOGICAL" }, { "name": "Multivirus-specific T cells Dose Level 2", "type": "BIOLOGICAL" }, { "name": "Multivirus-specific T cells Dose Level 3", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 21, "start_date": "2012-09", "completion_date": "2017-09", "has_results": true, "last_update_posted_date": "2019-05-30", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570283" }, { "nct_id": "NCT04390113", "title": "Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "BK Virus Infection", "Hemorrhagic Cystitis" ], "interventions": [ { "name": "Posoleucel (ALVR105)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 97, "start_date": "2021-03-18", "completion_date": "2024-01-30", "has_results": true, "last_update_posted_date": "2024-05-14", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 25, "location_summary": "Duarte, California • Los Angeles, California • New Haven, Connecticut + 21 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04390113" }, { "nct_id": "NCT02276820", "title": "Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adenovirus Infection" ], "interventions": [ { "name": "Viralym-A", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2017-12-07", "completion_date": "2019-12", "has_results": false, "last_update_posted_date": "2018-07-23", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02276820" }, { "nct_id": "NCT02313857", "title": "Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "CMV Infections" ], "interventions": [ { "name": "Viralym-C", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10, "start_date": "2015-09", "completion_date": "2018-02", "has_results": false, "last_update_posted_date": "2018-12-26", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02313857" }, { "nct_id": "NCT02313844", "title": "Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "BK Virus Infection" ], "interventions": [ { "name": "Viralym-B", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AlloVir", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2018-03-01", "completion_date": "2019-12", "has_results": false, "last_update_posted_date": "2018-04-09", "last_synced_at": "2026-09-25T16:21:10.304Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02313844" } ] }